Polypharmazie und Schmerztherapie
详细信息 查看全文
- 作者：Markus Gosch (1)
Birgit B?hmdorfer (2)
Ursula Benvenuti-Falger (1)
Peter Dovjak (3)
Bernhard Iglseder (4)
Monika Lechleitner (1)
Ronald Otto (5)
Regina E. Roller (5)
Ulrike Sommeregger (6) - 关键词：Pain ; Polypharmacy ; Adverse drug effects ; Drug interaction ; Inappropriate medication ; Schmerzen ; Polypharmazie ; Unerwünschte Arzneimittelwirkungen ; Interaktionen ; Ungeeignete Medikation
- 刊名：Wiener Medizinische Wochenschrift
- 出版年：2010
- 出版时间：June 2010
- 年：2010
- 卷：160
- 期：11-12
- 页码：286-292
- 全文大小：117KB
- 参考文献：1. Basler HD, Hesselbarth S, Schuler M. Schmerzdiagnostik und -therapie in der Geriatrie. Teil 1. Schmerzdiagnostik. Schmerz, 18: 317-26, 2004
2. Davies MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging, 20: 23-7, 2003 CrossRef
3. Hadjistavropoulos T, Herr K, Turk DC, et al. An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain, 23(Suppl): S1–S43, 2007 CrossRef
4. Stoehr GP, Ganguli M, Seaberg EC, et al. Over-the-counter medication use in an older rural community: the MoVIES Project. J Am Geriatr Soc, 45: 158-65, 1997
5. Rottlaender D, Scherner M, Schneider T, et al. Multimedikation, Compliance und Zusatzmedikation bei Patienten mit kardiovaskul?ren Erkrankungen. Dtsch Med Wochenschr, 132: 139-44, 2007 CrossRef
6. Junius Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract, 24: 14-9, 2007 CrossRef
7. Sawyer P, Bodner EV, Ritchie CS, et al. Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother, 4: 316-24, 2006 CrossRef
8. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ, 329: 15, 2004 CrossRef
9. Laroche M, Charmes J, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly. Br J Clin Pharmacol, 63: 177-86, 1997 CrossRef
10. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med, 165: 2414-419, 2005 CrossRef
11. Schuler J, Dückelmann C, Beindl W, et al. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wien Klin Wochenschr, 120: 733-41, 2008 CrossRef
12. Wirth HP, Hürlimann R, Flückiger T. NSAR und Cox-2-Hemmer: die h?ufigsten unerwünschten Wirkungen. Schweiz Med Forum, 6: 284-89, 2006
13. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). JAGS, 50: 1962-968, 2002 CrossRef
14. ATC-DDD system (online), available from URL: http://www.whocc.no/atcddd/atsystem.html#6 (assessed 18 February 2008)
15. Baraldi A, Ballestri M, Rapana R, et al. Acute renal failure of medical type in an elderly population. Nephrol Dial Transplant, 13(Suppl 7): 25-9, 1998 CrossRef
16. Smets HL, De Haes JF, De Swaef A, et al. Exposure of the elderly to potential nephrotoxic drug combinations in Belgium. Pharmacoepidemiol Drug Saf, 17: 1014-019, 2008 CrossRef
17. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underecognized public health problem. Arch Intern Med, 160: 777-84, 2000 CrossRef
18. Johnson AG. NSAIDs and increased blood pressure. What is clinical significance? Drug Saf, 17: 277-89, 1997 CrossRef
19. Johnson AG, Nguyan TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med, 121: 289-00, 1994
20. de Leeuw PW. Nonsteriodal anti-inflammatory drugs and hypertension. The risk in perspective. Drugs, 51: 179-87, 1996 CrossRef
21. MacDonald TM, Wie L. Effect of ibuprufen on cardioprotective effect of aspirin. Lancet, 361: 573-74, 2003 CrossRef
22. Garcia-Rodriguez L, Varas-Lorenzo C, Maguire A, et al. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation, 109: 3000-006, 2004 CrossRef
23. Delaney JA, Opatrny L, Brophy JM, et al. Drug–drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ, 177: 347-51, 2007
24. Skop BP, Brown TM. Potential bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics, 37: 12-6, 1996
25. Verbeuren TJ. Synthesis, storage, release and metabolism of 5-hydroxyltryptamine in peripheral tissues. In: Fozard JR (ed) The Peripheral Actions of 5-hydroxyltryptamine. New York, NY: Oxford University Press, pp 1-5, 1989
26. De Clerck F. The role of serotonin in thrombogenesis. Clin Physiol Biochem, 8(Suppl 3): 40-9, 1990
27. Loke YK, Trivel AN, Ingh S. Meta-analysis: gastrointestinal bleeding due to interaction between selektive serotonin reuptake inhibitors and non steroidal inflammatory drugs. Aliment Pharmacol Ther, 27: 31-0, 2008
28. Janknegt R. Drug interactions with quinolones. J Antimicrob Chemoter, 26(Suppl D): 7-9, 1990
29. Iqbal Z, Khan A, Naz A, et al. Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single dose, two-period crossover study in healthy adult volunteers. Clin Drug Investig, 29: 4, 275-81, 2009
30. Ball P, Tillotson G. Tolerability of flouroquinolone antibiotics: past, present and future, Drug Saf, 13: 343, 1996 CrossRef
31. Sone H, Takahashi A, Yamada N. Ibuprofen-related hypoglycaemia in a patient receiving sulfonylurea. Ann Intern Med, 134: 344, 2001
32. Collin M, Mucklow JC. Drug interactions, renal impairment and hypoglycaemia in a patient with Type II diabetes. Br J Clin Pharmacol, 48: 134-37, 1999 CrossRef
33. Sinatra RS, Jahr JS, Reynolds LW, et al. Efficacy and safety of single and repeated administration of 1 gram intravenous acetominophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology, 102: 822-32, 2005 CrossRef
34. Gleiter CH. Paracetamol -das sichere Analgetikum. Internist, 38: 707-12, 1997 CrossRef
35. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selektive cyclooxygenase-2 inhibitor in man. FASEB J, 22: 383-90, 2008 CrossRef
36. Gonzalez-Perez A, Garcia Rodriguez L. Upper gastrointestinal complications among users of paracetamol. Basic Clin Pharmacol Toxicol, 98: 297-03, 2006 CrossRef
37. Mahe I, Bertrand N, Drouet L, et al. Interaction between paracetamol and warfarin in patients: a double-blind, pacebo-controlled, randomized study. Haematologica, 91: 1621-627, 2006
38. Forman JP, Stampfer MJ, Curhan GC. Non-narcotic analgesic dose and risk of incident hypertension in US women. Hypertension, 46: 500-07, 2005 CrossRef
39. Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation, 113: 1578-587, 2006 CrossRef
40. Larsen A, Poison J, Fontana R, et al. Acetaminophen-induced acute liver failure: results of a US Multicenter, prospective study. Hepatology, 42: 1364-372, 2005 CrossRef
41. Perucca E, Richens A. Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs. Br J Clin Pharmacol, 7: 201-06, 1979
42. Toes MJ, Jones AL, Prescott L. Drug interactions with paracetamol. Am J Ther, 12: 56-6, 2005 CrossRef
43. Reinhardt N, Jantos R, Sinning C, et al. Renaissance eines Analgetikums. Pharmazeutische Zeitschrift, 32, 2006 (online)
44. Campos C, de Gregorio R, Garcia-Nieto R, et al. Regulation of cyclooxygenase activity by metamizol. Eur J Pharmacol, 378: 339-47, 1999 CrossRef
45. Verspohl EJ. Analgetika mit antipyretischer und antiphlogistischer Wirkungskomponente. In: Ammon HPT (Hrsg) Arzneimittelneben- und -wechselwirkungen. 4. Auflage, WVG: Stuttgart, pp 420-24, 2001
46. Fachinformation Novalgin?, August 2004. Aventis Pharma
47. Levy M. Risks of agranulocytosis and aplastic anaemia: the international agranulocytosis and aplastic anaemia study. J Am Med Assoc, 256: 1749-757, 1986 CrossRef
48. Arzneimittelkommission der dt. ?rzteschaft, Arzneiverordnungen. 21. Auflage, pp 214-16, 2006
49. Saussele T, Burk O, Blievernicht JK, et al. Selective induction of human hepatic cytochromes P450 2B6 and 3A4 by metamizole. Clin Pharmacol Ther, 83: 265-74, 2007 CrossRef
50. Enggaard Th, Poulsen L, Arendt-Nielsen L, et al. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6. Anesth Analg, 102: 146-50, 2006 CrossRef
51. Dayer P, Desmeules J, Collart L. Pharmacology of tramadol. Drugs, 53(Suppl 2): 18-4, 1997 CrossRef
52. Opioids+benzodiazepines, stockleys drug interactions, medicines complete. In: Baxter K (ed) London, UK: RPS Publishing, http://www.medicinescomplete.com/mc, 01/08/2008
53. Serotonin reuptake inhibitors/tramadol. In: Tatro DS (ed) Drug Interaction Facts, Facts and Comparisons 4.0. St. Louis, MI, USA: Wolters Kluwer Health Inc., http://online.factsandcomparisons.com, 14/05/2009
54. Kesavan S, Sobala GM. Serotonin syndrome with fluoxetine plus tramadol. J R Soc Med, 92: 474-75, 1999
55. Boyd IW. Tramadol and seizures. Med J Aust, 182: 595-96, 2005
56. Pisani F, Oteri G, Costa C, et al. Effects of psychotropic drugs on seizure threshold. Drug Saf, 25: 91-10, 2002 CrossRef
57. Desmeules JA. The tramadol option. Eur J Pain, 4(Suppl A): 15-1, 2000
58. Hedges D, Jeppson K, Whitehead P. Antipsychotic medication and seizures: a review. Drugs Today, 39: 551-57, 2003 CrossRef
59. Potschka H, Friderichs E, Loscher W. Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy. Br J Pharmacol, 131: 203-12, 2000 CrossRef
60. Tramadol Hydrochloride, American Hospital Formulary Service Drug Information, Medicines Complete. In: McEvoy GK (ed) London, UK: RPS Publishing, http://www.medicinescomplete.com/mc, 07/07/2008
61. Opioids+Antiepileptics; Enzyme-inducing, Stockleys Drug Interactions, Medicines Complete. In: Baxter K (ed) London, UK: RPS Publishing, http://www.medicinescomplete.com/mc, 15/12/2008
62. Arcioni R, della Rocca M, Romanò S, et al. Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans. Anesth Analg, 94: 1553-557, 2002 CrossRef
63. De Witte JL, Schoenmaekers B, Sessler DI, et al. The analgesic efficacy of tramadol is impaired by concurrent administration of ondansetron. Anesth Analg, 92: 1319-321, 2001 CrossRef
64. Hedenmalm K, Lindh JD, Sawe J, et al. Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Eur J Clin Pharmacol, 60: 369-72, 2004 CrossRef
65. Sabbe JR, Sims PJ, Sims MH. Tramadol-warfarin interaction. Pharmacotherapy, 18: 871-73, 1998
66. Penning-van Beest F, Erkens J, Petersen KU, et al. Main comedications associated with major bleeding during anticoagulant therapy with coumarins. Eur J Clin Pharmacol, 61: 439-44, 2005 CrossRef
67. Rang ST, Field J, Irving C. Serotonin toxicity caused by an interaction between fentanyl and paroxetine. Can J Anaesth, 55: 521-25, 2008 CrossRef
68. Ailawadhi S, Sung KW, Carlson LA, et al. Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther, 32: 199-02, 2007 CrossRef
69. Won A, Lapane KL, Vallow S, et al. Long-term effects of analgesics in a population of elderly nursing home residents with peristent nonmalignant pain. J Gerontol A Biol Sci Med Sci, 61: 165-69, 2006 - 作者单位：Markus Gosch (1)
Birgit B?hmdorfer (2)
Ursula Benvenuti-Falger (1)
Peter Dovjak (3)
Bernhard Iglseder (4)
Monika Lechleitner (1)
Ronald Otto (5)
Regina E. Roller (5)
Ulrike Sommeregger (6)
1. Abteilung für Innere Medizin und Akutgeriatrie, Landeskrankenhaus Hochzirl, Zirl, Austria
2. Anstaltsapotheke, Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhügel, Wien, Austria
3. Abteilung für Akutgeriatrie/Remobilisation, Landeskrankenhaus Gmunden, Gmunden, Austria
4. Universit?tsklinik für Geriatrie, Paracelsus Medizinische Privatuniversit?t, Salzburg, Austria
5. Universit?tsklinik für Innere Medizin, Medizinische Universit?t Graz, Graz, Austria
6. Abteilung für Akutgeriatrie, Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhügel, Wien, Austria - ISSN：1563-258X
文摘